SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NEUE, ESSA, LTRPA on Behalf of Shareholders
- NEW YORK , Feb. 10, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: NeueHealth, Inc. (NYSE: NEUE)'s sale to an affiliate of New Enterprise Associates for $7.33 per share in cash. If you are a NeueHealth shareholder, click here to learn more about your rights and options.
- 02/10/2025
|
Bronstein, Gewirtz & Grossman, LLC Is Investigating NeueHealth, Inc. (NEUE) And Encourages Shareholders to Connect
- NEW YORK CITY, NY / ACCESS Newswire / February 9, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between NeueHealth, Inc. ("NeueHealth") (NYSE: NEUE) and New Enterprise Associates ("NEA") (: ). Investors who purchased NeueHealth and continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NEUE.
- 02/09/2025
|
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against NeueHealth, Inc. (NEUE) And Encourages Shareholders to Reach Out
- NEW YORK CITY, NY / ACCESS Newswire / February 5, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between NeueHealth, Inc. ("NeueHealth") (NYSE: NEUE) and New Enterprise Associates ("NEA") (: ). Investors who purchased NeueHealth and continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NEUE.
- 02/05/2025
|
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against NeueHealth, Inc. (NEUE) and Encourages Shareholders to Learn More About the Investigation
- NEW YORK CITY, NY / ACCESS Newswire / February 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between NeueHealth, Inc. ("NeueHealth") (NYSE: NEUE) and New Enterprise Associates ("NEA") (: ). Investors who purchased NeueHealth and continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NEUE.
- 02/02/2025
|
NeueHealth, Inc. Is Being Investigated For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESS Newswire / January 30, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
- 01/30/2025
|
The Schall Law Firm Invites Investors With Losses To Join An Investigation Into NeueHealth, Inc. For Securities Fraud
- LOS ANGELES, CA / ACCESS Newswire / January 29, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
- 01/29/2025
|
NeueHealth, Inc. (NEUE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
- NEW YORK CITY, NY / ACCESS Newswire / January 29, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between NeueHealth, Inc. ("NeueHealth") (NYSE: NEUE) and New Enterprise Associates ("NEA") (: ). Investors who purchased NeueHealth and continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NEUE.
- 01/29/2025
|
NeueHealth, Inc. Is Being Investigated For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESS Newswire / January 28, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
- 01/28/2025
|
The Schall Law Firm Invites Investors With Losses To Join An Inquiry Into NeueHealth, Inc. For Securities Fraud
- LOS ANGELES, CA / ACCESS Newswire / January 27, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
- 01/27/2025
|
NeueHealth, Inc. Is Being Investigated For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESS Newswire / January 26, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
- 01/26/2025
|
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against NeueHealth, Inc. (NEUE) and Encourages Investors to Learn More About the Investigation
- NEW YORK CITY, NY / ACCESS Newswire / January 26, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between NeueHealth, Inc. ("NeueHealth") (NYSE: NEUE) and New Enterprise Associates ("NEA") (: ). Investors who purchased NeueHealth and continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NEUE.
- 01/26/2025
|
The Schall Law Firm Invites Investors With Losses To Join An Inquiry Into NeueHealth, Inc. For Securities Fraud
- LOS ANGELES, CA / ACCESS Newswire / January 25, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
- 01/25/2025
|
NeueHealth, Inc. Is Being Investigated For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESS Newswire / January 24, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
- 01/24/2025
|
The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into NeueHealth, Inc. For Securities Fraud
- LOS ANGELES, CA / ACCESS Newswire / January 23, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
- 01/23/2025
|
NeueHealth, Inc. Is Being Investigated For Securities Law Violations And Affected Investors Are Urged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESS Newswire / January 22, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
- 01/22/2025
|
NeueHealth, Inc. (NEUE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
- NEW YORK CITY, NY / ACCESS Newswire / January 22, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between NeueHealth, Inc. ("NeueHealth") (NYSE: NEUE) and New Enterprise Associates ("NEA") (: ). Investors who purchased NeueHealth and continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NEUE.
- 01/22/2025
|
The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into NeueHealth, Inc. For Securities Fraud
- LOS ANGELES, CA / ACCESS Newswire / January 21, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
- 01/21/2025
|
NeueHealth, Inc. Is Being Investigated For Securities Law Violations And Affected Investors Are Urged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESS Newswire / January 20, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
- 01/20/2025
|
The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into NeueHealth, Inc. For Securities Fraud
- LOS ANGELES, CA / ACCESS Newswire / January 19, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
- 01/19/2025
|
Bronstein, Gewirtz & Grossman, LLC Is Investigating NeueHealth, Inc. (NEUE) And Encourages Investors to Connect
- NEW YORK CITY, NY / ACCESS Newswire / January 19, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between NeueHealth, Inc. ("NeueHealth") (NYSE: NEUE) and New Enterprise Associates ("NEA") (: ). Investors who purchased NeueHealth and continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NEUE.
- 01/19/2025
|
NeueHealth, Inc. Is Being Investigated For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESS Newswire / January 18, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
- 01/18/2025
|
The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into NeueHealth, Inc. For Securities Fraud
- LOS ANGELES, CA / ACCESS Newswire / January 17, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
- 01/17/2025
|
NeueHealth, Inc. Is Being Investigated For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESS Newswire / January 16, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
- 01/16/2025
|
Bronstein, Gewirtz & Grossman, LLC Encourages NeueHealth, Inc. (NEUE) Stockholders to Inquire about Securities Investigation
- NEW YORK CITY, NY / ACCESSWIRE / January 15, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between NeueHealth, Inc. ("NeueHealth") (NYSE: NEUE) and New Enterprise Associates ("NEA") (: ). Investors who purchased NeueHealth and continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NEUE.
- 01/15/2025
|
The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into NeueHealth Inc. For Securities Fraud
- LOS ANGELES, CA / ACCESSWIRE / January 15, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
- 01/15/2025
|
NeueHealth Inc. Is Being Investigated For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESSWIRE / January 14, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
- 01/14/2025
|
The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into NeueHealth, Inc. For Securities Fraud
- LOS ANGELES, CA / ACCESSWIRE / January 13, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
- 01/13/2025
|
NeueHealth Inc Is Being Investigated For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESSWIRE / January 12, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
- 01/12/2025
|
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against NeueHealth, Inc. (NEUE) And Encourages Stockholders to Reach Out
- NEW YORK CITY, NY / ACCESSWIRE / January 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between NeueHealth, Inc. ("NeueHealth") (NYSE: NEUE) and New Enterprise Associates ("NEA") (: ). Investors who purchased NeueHealth and continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NEUE.
- 01/12/2025
|
The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into NeueHealth, Inc. For Securities Fraud
- LOS ANGELES, CA / ACCESSWIRE / January 11, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
- 01/11/2025
|
NeueHealth Inc Is Being Investigated For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESSWIRE / January 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
- 01/10/2025
|
The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into NeueHealth, Inc. For Securities Fraud
- LOS ANGELES, CA / ACCESSWIRE / January 9, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
- 01/09/2025
|
NeueHealth Inc Is Being Investigated For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESSWIRE / January 8, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
- 01/08/2025
|
Bronstein, Gewirtz & Grossman, LLC Is Investigating NeueHealth, Inc. (NEUE) And Encourages Stockholders to Connect
- NEW YORK CITY, NY / ACCESSWIRE / January 8, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between NeueHealth, Inc. ("NeueHealth") (NYSE: NEUE) and New Enterprise Associates ("NEA") (: ). Investors who purchased NeueHealth and continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NEUE.
- 01/08/2025
|
The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into NeueHealth, Inc. For Securities Fraud
- LOS ANGELES, CA / ACCESSWIRE / January 7, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
- 01/07/2025
|
NEUEHEALTH INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NeueHealth, Inc. - NEUE
- NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of NeueHealth, Inc. (NYSE: NEUE) to an affiliate of New Enterprise Associates. Under the terms of the proposed transaction, shareholders of NeueHealth will receive $7.33 in cash for each share of NeueHealth that they own. KSF is seeking to determine whether this consideration and the process that led to it are ad.
- 01/06/2025
|
NeueHealth Inc Is Being Investigated For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESSWIRE / January 6, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
- 01/06/2025
|
NeueHealth Stock - Is the Proposed Acquisition of NeueHealth Fair to NEUE Shareholders? - Kehoe Law Firm, P.C.
- PHILADELPHIA, PA / ACCESSWIRE / January 6, 2025 / Kehoe Law Firm, P.C. is investigating potential claims on behalf of investors of NeueHealth, Inc. ("NeueHealth") (NYSE:NEUE) regarding the adequacy and fairness of the proposed acquisition of NeueHealth.
- 01/06/2025
|
The Schall Law Firm Invites Shareholders To Join An Inquiry Into NeueHealth, Inc. For Securities Fraud
- LOS ANGELES, CA / ACCESSWIRE / January 5, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
- 01/05/2025
|
NeueHealth, Inc. (NEUE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
- NEW YORK CITY, NY / ACCESSWIRE / January 5, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between NeueHealth, Inc. ("NeueHealth") (NYSE: NEUE) and New Enterprise Associates ("NEA") (: ). Investors who purchased NeueHealth and continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NEUE.
- 01/05/2025
|
NeueHealth Inc Is Being Investigated For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESSWIRE / January 4, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
- 01/04/2025
|
NeueHealth Stock - Is the Proposed Acquisition of NeueHealth By An Affiliate of Its Controlling Shareholder Fair to NEUE Shareholders? - Kehoe Law Firm, P.C.
- PHILADELPHIA, PA / ACCESSWIRE / January 3, 2025 / Kehoe Law Firm, P.C. is investigating potential claims on behalf of investors of NeueHealth, Inc. ("NeueHealth") (NYSE:NEUE ) regarding the adequacy and fairness of the proposed acquisition by NeueHealth's controlling shareholder, New Enterprise Associates ("NEA").
- 01/03/2025
|
The Schall Law Firm Invites Shareholder Contributions To An Inquiry Into NeueHealth Inc For Securities Fraud
- LOS ANGELES, CA / ACCESSWIRE / January 3, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
- 01/03/2025
|
NeueHealth Inc. Is Being Investigated For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESSWIRE / January 2, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
- 01/02/2025
|
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against NeueHealth, Inc. (NEUE) and Encourages Stockholders to Learn More About the Investigation
- NEW YORK CITY, NY / ACCESSWIRE / January 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between NeueHealth, Inc. ("NeueHealth") (NYSE: NEUE) and New Enterprise Associates ("NEA") (: ). Investors who purchased NeueHealth and continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NEUE.
- 01/02/2025
|
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ML, NEUE, LTRPA on Behalf of Shareholders
- NEW YORK , Jan. 1, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: MoneyLion Inc. (NYSE: ML)'s sale to Gen Digital Inc. Under the terms of the proposed transaction, MoneyLion shareholders will receive $82.00 per share in cash, plus one contingent value right per share entitling the holder to a contingent payment in the form of shares of Gen common stock. If you are a MoneyLion shareholder, click here to learn more about your legal rights and options.
- 01/01/2025
|
The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into NeueHealth, Inc. For Securities Fraud
- LOS ANGELES, CA / ACCESSWIRE / December 31, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
- 12/31/2024
|
NeueHealth Inc Is Being Investigated For Securities Law Violations And Impacted Investors Are Encouraged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESSWIRE / December 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
- 12/30/2024
|
Bronstein, Gewirtz & Grossman, LLC Encourages NeueHealth, Inc. (NEUE) Investors to Inquire about Securities Investigation
- NEW YORK CITY, NY / ACCESSWIRE / December 29, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between NeueHealth, Inc. ("NeueHealth") (NYSE: NEUE) and New Enterprise Associates ("NEA") (: ). Investors who purchased NeueHealth and continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NEUE.
- 12/29/2024
|
The Schall Law Firm Urges Shareholder Participation In An Inquiry Into NeueHealth, Inc. For Securities Fraud
- LOS ANGELES, CA / ACCESSWIRE / December 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
- 12/28/2024
|
The Schall Law Firm Urges Shareholder Participation In An Inquiry Into NeueHealth, Inc. For Securities Fraud
- LOS ANGELES, CA / ACCESSWIRE / December 27, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
- 12/27/2024
|
NeueHealth Inc Is Being Investigated For Securities Law Violations And Impacted Investors Are Invited To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESSWIRE / December 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
- 12/26/2024
|
The Schall Law Firm Urges Shareholder Participation In An Inquiry Into NeueHealth, Inc. For Securities Fraud
- LOS ANGELES, CA / ACCESSWIRE / December 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
- 12/24/2024
|
NEUE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces an Investigation into NeueHealth, Inc. and Encourages Investors to Contact the Firm
- NEW YORK CITY, NY / ACCESSWIRE / December 24, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between NeueHealth, Inc. ("NeueHealth") (NYSE:NEUE) and New Enterprise Associates ("NEA") (: ). Investors who purchased NeueHealth and continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NEUE.
- 12/24/2024
|
NEUE Investors Have the Opportunity to Join Investigation of NeueHealth, Inc. with the Schall Law Firm
- LOS ANGELES--(BUSINESS WIRE)--NEUE Investors Have the Opportunity to Join Investigation of NeueHealth, Inc. with the Schall Law Firm.
- 12/24/2024
|
NEUE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of NeueHealth, Inc. Is Fair to Shareholders
- NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of NeueHealth, Inc. (NYSE: NEUE) to an affiliate of New Enterprise Associates for $7.33 per share in cash is fair to NeueHealth shareholders. Halper Sadeh encourages NeueHealth shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation conce.
- 12/23/2024
|
NeueHealth to be taken private by New Enterprise Associates in $1.3 billion deal
- Health insurer NeueHealth said on Monday that an affiliate of New Enterprise Associates and a consortium of investors would take it private at an enterprise value of about $1.3 billion.
- 12/23/2024
|
NeueHealth to Be Taken Private by NEA and Consortium of Investors
- DORAL, Fla.--(BUSINESS WIRE)--NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSE: NEUE), the value-driven healthcare company, today announced that it has entered into a definitive merger agreement pursuant to which the Company will be acquired by an affiliate of New Enterprise Associates (“NEA”) at an enterprise value of approximately $1.3 billion. Upon completion of the transaction, NeueHealth will become a privately held company with the flexibility and resources to continue advancing its.
- 12/23/2024
|
NeueHealth, Inc. (NEUE) Q3 2024 Earnings Conference Call Transcript
- NeueHealth, Inc. (NYSE:NEUE ) Q3 2024 Earnings Conference Call November 7, 2024 8:00 AM ET Company Participants Emily Lombardi - Assistant Vice President Mike Mikan - President and CEO Jay Matushak - CFO Conference Call Participants Operator Ladies and gentlemen, welcome to the NeueHealth Third Quarter 2024 Earnings Call. My name is Kenneth, and I will be coordinating your call today.
- 11/10/2024
|
Neuehealth Reports Third Quarter 2024 Results
- DORAL, Fla.--(BUSINESS WIRE)--NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSE: NEUE), the value-driven healthcare company, today reported financial results for its third quarter ended September 30, 2024. “We are pleased to report another quarter of strong financial performance as we continue to build on the positive momentum we have generated so far this year,” said Mike Mikan, President and CEO of NeueHealth. “We have delivered Adjusted EBITDA profitability for three consecutive quarter.
- 11/07/2024
|
NeueHealth Acquires Full Ownership of Centrum Health
- DORAL, Fla.--(BUSINESS WIRE)--NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSE: NEUE), the value-driven healthcare company, today announced that Centrum Health, one of the Company's value-driven clinic brands, became a wholly owned subsidiary through the Company's acquisition of the remaining 25% equity interest of the business that it did not already own. This action simplifies NeueHealth's corporate structure, streamlining operations to support its ongoing focus on advancing its value-d.
- 10/30/2024
|
NeueHealth (NEUE) Upgraded to Buy: What Does It Mean for the Stock?
- NeueHealth (NEUE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- 09/19/2024
|
NeueHealth, Inc. (NEUE) Q2 2024 Earnings Call Transcript
- NeueHealth, Inc. (NYSE:NEUE ) Q2 2024 Earnings Conference Call August 7, 2024 8:00 AM ET Company Participants Emily Lombardi - Investor Relations Mike Mikan - President & Chief Executive Officer Jay Matushak - Chief Financial Officer Conference Call Participants Operator Good morning, all. Welcome to the NeueHealth Q2 2024 Earnings Call.
- 08/07/2024
|
NeueHealth Secures up to $150 Million in New Term Loan Facility with Hercules Capital
- DORAL, Fla.--(BUSINESS WIRE)--NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSE: NEUE), the value-driven healthcare company, today announced that it entered into a secured loan facility for up to $150 million with Hercules Capital, Inc. (NYSE: HTGC) ("Hercules"). “This financing puts us in a strong position to advance our differentiated care model and take the lead as the industry continues to shift to value-based care,” said Mike Mikan, President and CEO of NeueHealth. “We have establishe.
- 06/24/2024
|
NeueHealth Receives NYSE Non-Compliance Letter Regarding Market Capitalization Requirements
- DORAL, Fla.--(BUSINESS WIRE)--NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSE: NEUE), the value-driven healthcare company, today announced that on June 12, 2024, the Company received a written notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that the Company no longer satisfies the continued listing standards set forth under Section 802.01B of the NYSE's Listed Company Manual. The notice cited that the Company's average market capitalization over a consecutive 30 tradi.
- 06/18/2024
|
The Cigna Group (NYSE:CI) and NeueHealth (NYSE:NEUE) Financial Analysis
- The Cigna Group (NYSE:CI – Get Free Report) and NeueHealth (NYSE:NEUE – Get Free Report) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, risk, valuation, earnings, analyst recommendations, profitability and dividends. Earnings and Valuation This table compares The Cigna Group and NeueHealth’s gross revenue, earnings per share and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio The Cigna Group $195.27 billion 0.49 $5.16 billion $12.18 27.81 NeueHealth $1.16 billion 0.04 -$1.15 billion ($130.73) -0.05 The Cigna Group has higher revenue and earnings than NeueHealth. NeueHealth is trading at a lower price-to-earnings ratio than The Cigna Group, indicating that it is currently the more affordable of the two stocks. Profitability This table compares The Cigna Group and NeueHealth’s net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets The Cigna Group 1.76% 17.24% 5.09% NeueHealth -89.78% -5.62% 2.57% Institutional & Insider Ownership 87.0% of The Cigna Group shares are owned by institutional investors. Comparatively, 63.9% of NeueHealth shares are owned by institutional investors. 0.6% of The Cigna Group shares are owned by company insiders. Comparatively, 64.3% of NeueHealth shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Risk and Volatility The Cigna Group has a beta of 0.57, suggesting that its share price is 43% less volatile than the S&P 500. Comparatively, NeueHealth has a beta of 0.78, suggesting that its share price is 22% less volatile than the S&P 500. Analyst Ratings This is a summary of current ratings and target prices for The Cigna Group and NeueHealth, as reported by MarketBeat. Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score The Cigna Group 0 2 10 1 2.92 NeueHealth 0 1 0 0 2.00 The Cigna Group currently has a consensus price target of $366.14, indicating a potential upside of 8.10%. NeueHealth has a consensus price target of $8.00, indicating a potential upside of 33.56%. Given NeueHealth’s higher probable upside, analysts clearly believe NeueHealth is more favorable than The Cigna Group. Summary The Cigna Group beats NeueHealth on 12 of the 15 factors compared between the two stocks. About The Cigna Group (Get Free Report) The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. In addition, it offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut. About NeueHealth (Get Free Report) NeueHealth, Inc., a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics. It operates risk-bearing clinics under the Centrum Health, AssociatesMD, and Premier Medical Associates brand names. The company also offers integrated system care solution, such as embedded pharmacy, laboratory, radiology, and population health focused specialty services; and chronic care management, transitions of care, and referral management services. The NeueSolutions segment enables providers and medical groups to succeed in performance-based arrangements; and participates in the centers for healthcare access to medicare beneficiaries. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Doral, Florida.
- 05/20/2024
|
NeueHealth, Inc. (NEUE) Q1 2024 Earnings Call Transcript
- NeueHealth, Inc. (NYSE:NEUE ) Q1 2024 Earnings Conference Call May 8, 2024 8:00 AM ET Company Participants Emily Lombardi - Investor Relations Mike Mikan - President and Chief Executive Officer Jay Matushak - Chief Financial Officer Conference Call Participants Marco Criscuolo - Nephron Research LLC Operator Good morning, everyone, and welcome to the NeueHealth Q1 2024 Earnings Call. My name is Drew, and I'll be the operator for today.
- 05/10/2024
|
NeueHealth Reports First Quarter 2024 Results
- DORAL, Fla.--(BUSINESS WIRE)--NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSE: NEUE), the value-driven healthcare company, today reported financial results for its First Quarter ended March 31, 2024. “We had a strong start to the year, continuing to advance our value-driven, consumer-centric care model as we build on our strong relationships with providers and payors to make high-quality healthcare more accessible and affordable for all populations across the ACA Marketplace, Medicare, a.
- 05/08/2024
|
NeueHealth to Host First Quarter 2024 Earnings Conference Call on May 8, 2024
- DORAL, Fla.--(BUSINESS WIRE)--NeueHealth, Inc. ("NeueHealth") (NYSE: NEUE), the value-driven healthcare company, today announced it will report First Quarter financial results before the financial markets open on Wednesday, May 8, 2024, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including dial-in number.
- 04/18/2024
|
NeueHealth Enters into Amendment to its Credit Facility
- DORAL, Fla.--(BUSINESS WIRE)--NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSE: NEUE), the value-driven healthcare company, today announced that it entered into an incremental amendment to its credit facility with New Enterprise Associates (“NEA”) that increases the term loan commitment by $30 million on April 8, 2024. The proceeds of the incremental commitment are intended to be used for general corporate purposes, including to support the Company's 2024 strategic priorities. In connecti.
- 04/09/2024
|
NeueHealth, Inc. (NEUE) Q4 2023 Earnings Call Transcript
- NeueHealth, Inc. Q4 2023 Earnings Conference Call March 6, 2024 12:00 AM ET Company Participants Emily Lombardi - Investor Relations Mike Mikan - President and CEO Jay Matushak - CFO Tomas Orozco - Executive Vice President Conference Call Participants Joshua Raskin - Nephron Research Operator Good morning. My name is Drew, and I'll be your conference operator today.
- 03/06/2024
|
NeueHealth Reports Fourth Quarter and Full Year 2023 Results
- DORAL, Fla.--(BUSINESS WIRE)--NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSE: NEUE), the value-driven healthcare company, today reported financial results for its fourth quarter and full year ended December 31, 2023. “We achieved significant milestones as a company this past year, completing the sale of our California Medicare Advantage business and fully focusing on where we have proven to have the greatest impact - through our care delivery and provider enablement business,” said Mike.
- 03/06/2024
|
